Corcept Therapeutics (CORT) Free Cash Flow Growth (1y) (2011 - 2026)
Corcept Therapeutics (CORT) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Corcept Therapeutics |
8.35 Bn |
8.01 Bn |
162.02 Mn |
-463.76% |
| Date | Value |
|---|
| Mar 31, 2026 |
-463.76% |
| Dec 31, 2025 |
-35.94% |
| Sep 30, 2025 |
-23.97% |
| Jun 30, 2025 |
8.51% |
| Mar 31, 2025 |
-80.36% |
| Dec 31, 2024 |
984.05% |
| Sep 30, 2024 |
35.53% |
| Jun 30, 2024 |
-3.35% |
| Mar 31, 2024 |
-8.48% |
| Dec 31, 2023 |
-83.42% |
| Sep 30, 2023 |
58.79% |
| Jun 30, 2023 |
134.08% |
| Mar 31, 2023 |
-26.33% |
| Dec 31, 2022 |
-32.42% |
| Sep 30, 2022 |
-31.41% |
| Jun 30, 2022 |
-59.25% |
| Mar 31, 2022 |
39.29% |
| Dec 31, 2021 |
42.50% |
| Sep 30, 2021 |
63.31% |
| Jun 30, 2021 |
-16.78% |
